Romosozumab
- Generic Name
- Romosozumab
- Brand Names
- Evenity 210 Mg Dose, Evenity
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 909395-70-6
- Unique Ingredient Identifier
- 3VHF2ZD92J
- Background
Romosozumab is a humanized monoclonal antibody indicated for the treatment of osteoperosis in postmenopausal women at high risk of fracture and patients who have failed in other treatments or are intolerant to other osteoperosis therapies. Romosozumab prevents bone resorption and induces the formation of bone though it is associated with an increased risk of...
- Indication
Romosozumab is indicated for the treatment of osteoporosis in post menopausal women at high risk of fractures and also in patients with osteoperosis who are intolerant to other treatments or who have failed in other treatments.
- Associated Conditions
- Osteoporosis
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath